Product Images Phyrago
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 13 images provide visual information about the product associated with Phyrago NDC 83858-105 by Nanocopoeia, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
carton-100 - carton 100
carton-140 - carton 140
This text describes a medication called PHYRAGO (dasatinib) in tablet form. It contains 140 mg of dasatinib in each tablet and is classified as a hazardous drug. It is important not to crush, cut, or chew the tablets but to swallow them whole. The dosage information can be found in the Prescribing Information. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F). It is distributed by Nanocopoeia, LLC in New Brighton, Minnesota, USA.*
core-20 - carton 20
This text is a medication label for PHYRAGO (dasatinib) tablets, warning that it is a hazardous drug and should not be crushed, cut, or chewed. It should be swallowed whole. Each tablet contains 20 mg of dasatinib. The label also includes information on dosage, storage temperature, and the distributor (Nanocopoeia, LLC). It mentions not to use if the inner seal of the bottle is broken or missing. The label includes details about the National Drug Code (NDC), prescription only nature (Rx only), and lot/expiry information.*
carton-50 - carton 50
This text is a description of a medication called PHYRAGO® (dasatinib) in tablet form. It is emphasized that the tablets should not be crushed, cut, or chewed but swallowed whole. Each tablet contains 50 mg of dasatinib. The warning label indicates that it is a hazardous drug. The text also provides instructions on storage conditions and dosage information, as well as details on the manufacturer and distribution. The medication is for prescription use only.*
carton-70 - carton 70
PHYRAGO is a hazardous drug in tablet form containing 70 mg of dasatinib. It is crucial not to crush, cut, or chew the tablets; they should be swallowed whole. Ensure the inner seal of the bottle is intact before use. Storage instructions recommend keeping the tablets at 20°C to 25°C (68°F to 77°F), with excursions allowed between 15°C and 30°C (59°F and 86°F). Each bottle contains 60 tablets. Prescription use only.*
carton-80 - carton 80
This text is a label for PHYRAGO (dasatinib) tablets, which are categorized as a hazardous drug. The warning advises against crushing, cutting, or chewing the tablets, emphasizing the importance of swallowing them whole. Each tablet contains 80 mg of dasatinib. The label also includes information about storage conditions (20°C to 25°C) and excursions permitted between 15°C and 30°C. The distributed by information mentions Nanocopoeia, LLC based in New Brighton, MN, USA. The label also specifies that the medication is for prescription use only and provides a National Drug Code (NDC) number.*
label-100 - label 100
label-140 - label 140
label-20 - label 20
This text provides information about a medication named Phyrago®, supplied in 60 tablets per bottle with NDC 83858-101-60. It includes instructions to swallow tablets whole and warns not to crush, cut, or chew them due to being a hazardous drug. Additional information may be available regarding dosage, administration, and potential side effects.*
label-50 - label 50
label-70 - label 70
label-80 - label 80
structure - structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
